10 Acadia Pharmaceuticals regulatory affairs leaders
Senior Vice President, Regulatory Affairs, Executive Director, Regulatory CMC and Director, Regulatory Affairs, Advertising & Promotion are among the titles these Acadia Pharmaceuticals regulatory affairs leaders hold today. A reader can learn how regulatory affairs leaders work at Acadia Pharmaceuticals from people who have held the role.
Professionals to explore
Amit Patel
LinkedInExperience: Executive Director, Regulatory Advertising, Promotion, and Labeling · Acadia Pharmaceuticals
Amit Patel has been Executive Director, Regulatory Advertising, Promotion, and Labeling at Acadia Pharmaceuticals since March 2022, with a headline naming them Head, Regulatory Advertising, Promotion, and Labeling. They were Sr. Director, Regulatory Advertising & Promotion at Acadia Pharmaceuticals (2019–2022) and Director, Regulatory Advertising & Promotion at Johnson & Johnson (2009–2010).
Daryl DeKarske
LinkedInExperience: Former Sr. Vice President, Global Head of Regulatory Affairs and Translational Sciences · Acadia Pharmaceuticals
Daryl DeKarske is a former Acadia Pharmaceuticals regulatory leader who was Sr. Vice President, Global Head of Regulatory Affairs and Translational Sciences at Acadia Pharmaceuticals from February 2017 to November 2022. They were Sr. Vice President, Head of Global Regulatory Affairs at Horizon (2022–2024), and have been a Biopharmaceutical Global Regulatory Affairs Strategy Consultant at RegStrat LLC since April 2024.
Giles Hulley
LinkedInExperience: Former Senior Director, Regulatory Affairs · Acadia Pharmaceuticals
Giles Hulley is a former Acadia Pharmaceuticals regulatory leader who was Senior Director, Regulatory Affairs at Acadia Pharmaceuticals from April 2022 to March 2023, in San Diego, California. They were Executive Director, Regulatory Affairs Strategy at Ventyx Biosciences (2023–2024) and Senior Director, Regulatory Affairs at AnaptysBio (2024–2026), and have been Executive Director, Regulatory Affairs at Candid Therapeutics since March 2026.
Heather Bradley
LinkedInExperience: Executive Director, Regulatory Affairs · Acadia Pharmaceuticals
Heather Bradley has been Executive Director, Regulatory Affairs at Acadia Pharmaceuticals since August 2020, with a headline reading Vice President, Regulatory Affairs at Acadia Pharmaceuticals Inc., based in San Diego, California. They were Senior Director, Global Regulatory Strategy (2018–2020) and Director, Global Regulatory Strategy, Neurology Business Group (2014–2018) at Eisai US.
Melissa Sadowski
LinkedInExperience: Director, Regulatory Affairs, Advertising & Promotion · Acadia Pharmaceuticals
Melissa Sadowski has been Director, Regulatory Affairs, Advertising & Promotion at Acadia Pharmaceuticals since September 2026, based in Warminster, Pennsylvania. They were Director, US Advertising and Promotion at EMD Serono, Inc. (2024–2026), and Director, Promotion Compliance (2023–2024) and Associate Director, Promotion Compliance (2020–2023) at Otsuka Pharmaceutical Companies (U.S.).
Michael Epstein, MS
LinkedInExperience: Former Executive Director, Regulatory Operations · Acadia Pharmaceuticals
Michael Epstein is a former Acadia Pharmaceuticals regulatory leader who was Executive Director, Regulatory Operations at Acadia Pharmaceuticals from April 2018 to April 2023, in Princeton, New Jersey, overseeing regulatory operations functions. Michael Epstein has been Head of Regulatory Operations and Submission Management at Cytokinetics since June 2024.
Paula Denlick, MPH, RAC
LinkedInExperience: Director, Regulatory CMC · Acadia Pharmaceuticals
Paula Denlick has been Director, Regulatory CMC at Acadia Pharmaceuticals since March 2024, based in San Diego, California. They were Senior Director, CMC Regulatory Affairs (2019–2023), Director, CMC Regulatory Affairs (2015–2019) and Associate Director, CMC Regulatory Affairs (2013–2015) at Intercept Pharmaceuticals.
Stephanie Kim
LinkedInExperience: Senior Vice President, Regulatory Affairs · Acadia Pharmaceuticals
Stephanie Kim has been Senior Vice President, Regulatory Affairs at Acadia Pharmaceuticals since September 2023, based in San Francisco, California. They were Vice President Regulatory Affairs at Ultragenyx (2019–2023) and Regulatory Affairs Head at Myovant Sciences (2017–2019), and their profile describes developing and implementing global regulatory strategies for a development portfolio.
Stephen Flore
LinkedInExperience: Director, Regulatory CMC, · Acadia Pharmaceuticals
Stephen Flore has been Director, Regulatory CMC at Acadia Pharmaceuticals since June 2022, based in San Diego, California. They were Director, Regulatory CMC at Pfizer in 2022 and at Arena Pharmaceuticals, Inc. (2019–2022), and Director, CMC at Samumed, LLC (2013–2019), and their profile describes managing a CMC team responsible for regulatory strategy.
Wade DeMond
LinkedInExperience: Executive Director, Regulatory CMC · Acadia Pharmaceuticals
Wade DeMond has been Executive Director, Regulatory CMC at Acadia Pharmaceuticals since April 2019, with a headline reading Executive Director, Head of Regulatory CMC at Acadia Pharmaceuticals, Inc., based in San Diego, California. They were Sr. Director, Regulatory CMC at Arena Pharmaceuticals, Inc. (2017–2019).
Choose the right perspective
Match the person's regulatory area, whether global strategy, CMC, operations or advertising and promotion, to the question you are working on. Weigh how recently someone held the role against the range of regulatory roles they held elsewhere.
Questions to take into the conversation
- 01How is regulatory work divided between strategy, CMC, operations and promotional review, and where do the hand-offs get hard?
- 02What did you change first when you took over your part of the regulatory function, and why?
- 03Which decisions does a regulatory leader own outright, and which are shared with clinical, medical or commercial colleagues?
Reaching Acadia Pharmaceuticals regulatory affairs leaders
How can I contact one of these Acadia Pharmaceuticals regulatory affairs leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Acadia Pharmaceuticals, based on profile data retrieved on October 26, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Acadia Pharmaceuticals regulatory affairs leaders?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Acadia Pharmaceuticals regulatory affairs leaders a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.